Foreshortened 40 to 30, the drs approx measurement.Patient outcome: no patient impact reported sg 12jan2024 patient/event info - notes: the following information has been received via phone call on 12jan2024.Sg 12jan2024 3.32 are images of the device or procedure available? no 3.33 at what stage of the procedure did the complaint occur? removing the introducer.3.34 details of access sheath used (name, fr size, length)? bmx penumbra 3.35 what was the target location for the stent? intracranial vessel 3.36 was the product inspected for kinks or damage before use? unknown 3.37 was the device used percutaneously? yes 3.38 was the device flushed through both flushing port before the procedure, as per ifu? n/a 3.39 was pre-dilation performed ahead of placement of the stent? n/a 3.40 was post-dilation performed after the placement of the stent? n/a 3.41 details of the wire guide used (name, diameter, hyrdophyllic)? n/a 3.42 did the patient exhibit difficult or altered anatomy (if altered please specify how it is altered)? focal stenosis 3.43 was resistance encountered when advancing the wire guide to the target location? no 3.44 was resistance encountered when advancing the delivery system to the target location? no 3.45 how did the physician deal with this resistance? n/a 3.46 was the approach ipsilateral or contralateral? ipsilateral 3.47 did the tip of the delivery system cross the target location? yes 3.48 was the delivery system tracked around a tight angle in the patient anatomy? 3.49 was the delivery system damaged/kinked/twisted during deployment? no 3.50 was the handle pulled towards the hub during deployment? no 3.51 was the delivery system pushed during deployment? n/a 3.52 was the stent deployed smoothly / without resistance? n/a ¿ if no, please detail any difficulty experienced during deployment: n/a 3.53 what artery was the stent placed in? unknown 3.54 was the stent fully deployed from the delivery system prior to removal of the delivery system? yes 3.55 did the patient have any pre-existing conditions? yes ¿ if yes, please specify: idiopathic intracranial hypertension 3.56 did the patient require any additional procedures as a result of this event? no 3.57 what intervention (if any) was required? n/a 3.58 was the secondary intervention performed during the same procedure as the device failure or was it scheduled for another day? n/a 3.59 were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G.Kink)? n/a.
|